article thumbnail

External control arms and debunking real-world data myths

pharmaphorum

However, like many other emerging healthcare technologies, they have been slow to gain traction and there is still confusion and scepticism around ECAs, stemming from a lack of precedence, step-by-step guidance and data to quantify their impact on drug development costs and clinical outcomes.

article thumbnail

Is India capable of ensuring equitable access to biopharmaceuticals?

Express Pharma

To help financially weak citizens gain access to affordable healthcare, the Pradhan Mantri Jan Arogya Yojana (PMJAY) was launched in 2018, providing about 500 million Indians with a ₹5 lakh family health insurance cover that include coverage for 1,400 medical procedures as well as critical diseases like prostate cancer.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Looking Ahead to the Lame Duck Session

Putting Patients First Blog

652 and HR 2630 ) would ensure that employer health plans offer a medically reasonable step therapy exceptions process, intended to help patients more quickly access effective treatments. Introduced by Senator Lisa Murkowski (R-AK) and Representative Brad Wenstrup (R-OH), the bipartisan Safe Step Act ( S.652

article thumbnail

NHC Comments on Help Committee Pandemic Preparedness RFI

Putting Patients First Blog

We encourage Congress to work with the FDA to analyze the impacts of these factors and consider ways to support this progress in future pandemic responses and apply the lessons to other areas of drug development including emerging new needs that have arisen due to COVID-19 infections, including supporting individuals with Long COVID.

article thumbnail

NHC Comments on Response to the Medicare Program; Request for Information on Medicare Advantage Data

Putting Patients First Blog

1 This trend underscores the importance of informed decision-making for those with chronic diseases and disabilities, who face crucial choices regarding their health care coverage – whether selecting between traditional Medicare and MA, choosing among MA plans, or navigating their selected plan to access necessary care. As of 2023, 30.8

article thumbnail

How Pharmacists Can Use Artificial Intelligence To Advance Their Practice: Insights From ChatGPT

ID Stewardship

We’ll dive into the many ways AI can assist pharmacists, from streamlining medication dispensing processes to enhancing patient education. Personalized Medication Recommendations : AI algorithms can process patient data, such as age, gender, medical conditions, and allergies, to generate tailored medication recommendations.

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. According to GlobalData, as of November 28, there were 316 generic and novel drugs marketed to treat obesity. Anti-obesity therapeutic landscape.